Epzicom/Kivexa is a fixed-dose combination medication used to treat HIV-1 infection in adults. It contains two antiretroviral drugs: abacavir and lamivudine.

Key features:

• Fixed-dose combination: Epzicom/Kivexa provides both abacavir and lamivudine in a single pill, making it convenient for patients.
• Oral administration: Epzicom/Kivexa is taken by mouth, making it a relatively easy medication to use.
• Effective: Epzicom/Kivexa has been shown to be effective in suppressing HIV-1 viral load to undetectable levels when used in combination with other antiretroviral drugs.
• Suitable for treatment-naive and treatment-experienced patients: Epzicom/Kivexa can be used in both people who are newly diagnosed with HIV and those who have already received treatment.